UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) November 7, 2003
ENDOLOGIX, INC.
| DELAWARE | 0-28440 | 68-0328265 | ||
|
|
||||
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
||
| 13900 ALTON PARKWAY, SUITE 122 IRVINE, CA (Address of principal executive offices) |
92618 (Zip Code) |
|||
| Registrant’s telephone number, including area code | (949) 595-7200 |
| Item 7. Financial Statements and Exhibits. | ||||||||
| Item 12. Disclosure of Results of Operations and Financial Condition. | ||||||||
| SIGNATURES | ||||||||
| EXHIBIT INDEX | ||||||||
| EXHIBIT 99.1 | ||||||||
Item 7. Financial Statements and Exhibits.
99.1 Press Release, dated November 10, 2003, issued by Endologix, Inc.
Item 12. Disclosure of Results of Operations and Financial Condition.
On November 10, 2003, Endologix, Inc. announced financial results for the third quarter ended September 30, 2003. A copy of the press release making this announcement is attached hereto as Exhibit 99.1 and incorporated herein by reference. The press release shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ENDOLOGIX, INC. | ||||
| Date: November 10, 2003 | By | /s/ David Richards | ||
| Chief Financial Officer and Secretary |
3
EXHIBIT INDEX
Exhibit 99.1 Earnings Release of Endologix, Inc. dated November 10, 2003
4